Previous
Mouscron-Peruwelz
Club Brugge
7:30 PM GMT
Game Details
Hellas Verona
Lazio
7:45 PM GMT
Game Details
São Paulo
Emelec
10:15 PM GMT
Leg 1
Game Details
New York Red Bulls
Sporting Kansas City
ESPN2 12:00 AM GMT
Game Details
Boca Juniors
Cerro Porteño
12:30 AM GMT
Leg 1
Game Details
Next
Schalke 04Schalke 04
FC AugsburgFC Augsburg
7:30 PM GMT
Game Details

Wolfsburg open Rodriguez contract talks

Transfers about an hour ago
Read

Hoeness 'warns Bayern over Reus'

Transfers 3 hours ago
Read

Barcelona top homegrown table

Europe 2 days ago
Read
Sep 4, 2014

Sammer: No 'exact prognosis' over Thiago Alcantara Bayern return

Bayern Munich have confirmed that Spain midfielder Thiago Alcantara will miss the World Cup with a knee injury.

Bayern Munich and Spain midfielder Thiago Alcantara's return date from a serious knee injury remains unclear, according to the German club's sporting executive Matthias Sammer.

Thiago, 23, tore a ligament in his right knee in late March against Hoffenheim and was initially ruled out for six to eight weeks. However, the former Barcelona starlet suffered a setback and needed to undergo a second surgery in May, only two days after returning to the squad, and has not played since -- missing out of the World Cup with Spain.

"We can't respectably say how long this will take. We can't give an exact prognosis," Sammer told kicker. "The development is very regrettable." 

Reports had suggested that Thiago could be back in team training as early as September but, on Thursday, kicker called that date "utopian."

Kicker also reported that Thiago's cortisone injection treatment in Barcelona has become a touchy subject between manager Pep Guardiola, who opted for treatment in Spain, and club doctor Muller-Wohlfahrt, who is against such treatment.

Comments

Use a Facebook account to add a comment, subject to Facebook's Terms of Service and Privacy Policy. Your Facebook name, photo & other personal information you make public on Facebook will appear with your comment, and may be used on ESPN's media platforms. Learn more.